The largest database of trusted experimental protocols

10 protocols using anti human igm f ab 2

1

Ramos B cell calcium flux assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ramos B cell calcium flux was measured as described (75 (link)). Protein tetramers were formed at a 4:1 molar ratio of protein to streptavidin (Invitrogen). Ramos cell lines stably expressing DH270 UCA, DH270.1, or CH65 IgM (76 (link)) were passaged (1:10) 4 days before calcium flux experiments. On the day of the experiment, cells with >95% viability were resuspended at 106 cells ml−1 in 2:1 ratio of RPMI media (GIBCO) + FLIPR Calcium 6 dye (Molecular Devices). Cells were plated in a U-bottom 96-well tissue culture plate (Costar) and incubated at 37°C 5% CO2 for 2 hours. In a black clear-bottom 96-well plate (Costar) containing 50 μl of RPMI media (GIBCO) + FLIPR Calcium 6 dye (Molecular Devices) (2:1 ratio) either 0.1 nmol of proteins or 50 μg ml−1 of anti-human IgM F(ab’)2 (Jackson Immuno) were added (based on a 100-μl volume). Using a FlexStation 3 multimode microplate reader (Molecular Devices), 50 μl of supernatant containing cells were transferred into the 50 μl of media containing protein or anti-human IgM F(ab’)2 (Jackson Immuno) and continuously read for 5 min. Relative fluorescent value units were background-subtracted and the data expressed as percentage of the IgM maximum signal (% IgM max).
+ Open protocol
+ Expand
2

B Cell Activation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated or thawed PBMC were washed with complete medium and counted. For qPCR, B cells were positively selected using anti-CD19 magnetic beads (Miltenyi Biotech). 0.5–1.0 × 106 cells per well were seeded in round-bottom 96-well plates in 200μL 10% FBS/RPMI 1640. Cells were stimulated with anti-human IgM F(ab′2) or anti-human Ig(A + G + M) F(ab′2) (Jackson Immuno-Research Laboratories) for indicated times. After stimulation, cells were collected for flow cytometry or qPCR.
+ Open protocol
+ Expand
3

Activated B-cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified CD19+ lymphocytes (1 × 105 cells/well) were cultured in 96-well plates in 50 μL medium (RPMI, 5%FBS) supplemented with 50 ng/mL rhIL-10 (Miltenyi Biotec), 20 U rhIL-2 (PeproTech), 0.1 μg/mL CD40L (Enzo Life Science) and 25 μg/mL anti-human IgM F(ab’)2 (Jackson ImmunoResearch). Purified CD4+ lymphocytes (2.5 × 105-3.5 × 105 cells/well) were cultured for 36 h with rhIL-2 (PeproTech, 50U/mL) at 37°C, 5% CO2 in 48-well plates that had been coated overnight with anti-CD3 (2 μg/mL) (BioLegend, clone OKT3) +/-anti-CD46 (2 μg/mL) (R&D Systems, clone 344519). To assess B-cell activation, 100 μL of T-cell supernatant was added to B cells and cultured for 5–10 days at 37°C, 5%CO2. To block the activity of IL-10, a neutralizing mAb to IL-10 (2.5 μg/mL) was used. To restore B-cell proliferation in mixtures containing T-cell supernatants rhIL-10 (1 μg/mL) was added.
+ Open protocol
+ Expand
4

B Cell Activation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated or thawed PBMC were washed with complete medium and counted. For qPCR, B cells were positively selected using anti-CD19 magnetic beads (Miltenyi Biotech). 0.5–1.0 × 106 cells per well were seeded in round-bottom 96-well plates in 200μL 10% FBS/RPMI 1640. Cells were stimulated with anti-human IgM F(ab′2) or anti-human Ig(A + G + M) F(ab′2) (Jackson Immuno-Research Laboratories) for indicated times. After stimulation, cells were collected for flow cytometry or qPCR.
+ Open protocol
+ Expand
5

Activation and Viability of Splenic B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenic B cells were purified by negative selection of CD43+ cells using anti-CD43 magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany). The purified B cells (1 × 107 cells/ml) were stimulated with 10 µg/mL anti-mouse IgM F(ab)′2 (Jackson ImmunoResearch, West Grove, PA, USA) or 10 µg/mL anti-human IgM F(ab)′2 (Jackson ImmunoResearch) and then lysed in lysis buffer [10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100 and 0.5 mM EDTA plus protease and phosphatase inhibitor cocktails (Nacalai Tesque)]. Samples were transferred to polyvinylidene difluoride membranes by electrophoresis and analysed by immunoblotting with antibodies against p-Syk (Tyr525/526) (C87C1) and Syk (D3Z1E) (Cell Signaling Technology, Danvers, MA, USA). The purified splenic B cells were cultured with or without 25 ng/ml BAFF (R&D Systems, Minneapolis, MN, USA) for 24, 48, or 72 h. The frequency of live B cells was assessed using TOPRO3 (Invitrogen) exclusion.
+ Open protocol
+ Expand
6

B-cell Activation Assay Using T-cell Supernatant

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified CD19+ lymphocytes (1 × 105 cells/well) were cultured in 96‐well plates in 50 μL medium (RPMI, 5%FBS) supplemented with 50 ng/mL rhIL‐10 (Miltenyi Biotec), 20 U rhIL‐2 (PeproTech), 0.1 μg/mL CD40L (Enzo Life Science) and 25 μg/mL anti‐human IgM F(ab’)2 (Jackson ImmunoResearch). Purified CD4+ lymphocytes (2.5 × 105‐3.5 × 105 cells/well) were cultured for 36 h with rhIL‐2 (PeproTech, 50U/mL) at 37°C, 5% CO2 in 48‐well plates that had been coated overnight with anti‐CD3 (2 μg/mL) (BioLegend, clone OKT3) +/‐anti‐CD46 (2 μg/mL) (R&D Systems, clone 344519). To assess B‐cell activation, 100 μL of T‐cell supernatant was added to B cells and cultured for 5–10 days at 37°C, 5%CO2. To block the activity of IL‐10, a neutralizing mAb to IL‐10 (2.5 μg/mL) was used. To restore B‐cell proliferation in mixtures containing T‐cell supernatants rhIL‐10 (1 μg/mL) was added.
+ Open protocol
+ Expand
7

PBMC Isolation, Stimulation, and Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated or thawed PBMC were washed with complete medium and counted. For qPCR, B cells were positively selected using anti-CD19 magnetic beads (Miltenyi Biotech). 0.5-1.0x10 6 cells per well were seeded in round-bottom 96-well plates in 200µl 10%FBS/RPMI 1640. Cells were stimulated with anti-human IgM F(ab¢2) or anti-human Ig(A+G+M) F(ab¢2) (Jackson Immuno-Research Laboratories) for indicated times. After stimulation, cells were collected for flow cytometry or qPCR.
To stain for flow cytometry, PBMC or tonsil cells were first incubated with Fc-Block (Biolegend) for 5 minutes at RT. Then 100ul of surface antibody cocktail (table S4) was added to each tube and incubated on ice for 30 minutes. Next, live/dead cell assay (Invitrogen) was applied for 15 minutes on ice. Intracellular staining was performed using Foxp3/Transcription factor staining buffer kit (eBioscience) following manufacture protocol. After intracellular staining, cells were washed and fixed in 100µl PBS/1% paraformaldehyde for 20 minutes at RT and then 200µl of PBS/5%BSA was added to dilute the fixative. Samples were analyzed on an 18-color LSR II flow cytometer (eBioscience) on the same day or after kept at 4°C overnight. Analyses were performed using FlowJo v.10 (Tree Star) and doublet exclusion was performed on all samples. Gating strategy is depicted in fig. S8.
+ Open protocol
+ Expand
8

B Cell Gene Expression and Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cells were cultured in R10 medium at 37 °C and 5% CO2. For gene expression analyses, cells were enriched for CD27CD10 B cells and plated at 3 × 106 cells per ml with preincubation for 1 hour at 37 °C with Emab (5 μg/ml) or hIgG1 isotype control (5 μg/ml; Sigma) or R10 medium and then stimulated with TLR7 agonist R848 (50 ng/ml; InvivoGen), F(ab′)2 anti-human IgM (5 μg/ml; Jackson ImmunoResearch Laboratories, Inc.), or a combination of R848 plus anti-IgM. In some cases, cells were pretreated with IFN-α at 1000 U/ml (PBL, Piscataway, NJ, USA). Samples were cultured for 12 hours, harvested, and used for RNA isolation. For cell proliferation experiments, cells were loaded with 2.5 μM CFSE (ThermoFisher Scientific) in PBS at 37 °C for 10 min, quenched with R10 medium, washed, stimulated, and then cultured for 3 days. For assessing cell survival and plasma cell differentiation, sorted B-cell subsets were placed in 96-well plates at a concentration of 2.5 × 106 cells per ml, treated with different stimuli, and analyzed by flow cytometry after 3–5 days of in-vitro cell culture.
+ Open protocol
+ Expand
9

B Cell Activation and Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total CD20+ B cells were plated at 100,000 cells/well in a 96-well-plate in RPMI 10% FBS and 2.5 μg/ml polyclonal F(ab’)2 anti-human IgM (Jackson Immunoresearch), 1.0 μg/ml CpG ODN2006 (In vivogen) or 2 μg/ml Gardiquimod (In vivogen). Expression of surface activation markers CD69 and CD86 was analyzed on gated CD19+CD27- IgD+ or IgD- cells after 48 hours by flow cytometry. For functional analysis of IGHD variants flow cytometrically sorted CD19+CD27IgM+IgD+ and CD19+CD27-IgM+IgD- B cells were stimulated by anti-human IgM or anti-human IgD antibodies. Expression of CD69 was analyzed after 48 hours.
+ Open protocol
+ Expand
10

Activation of Human B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total CD20+ B cells or naïve B cells were plated at 150,000 cells/well in a 96-well-plate in RPMI 10% FBS and 2.5 μg/mL polyclonal F(ab′)2 anti-human IgM (Jackson Immunoresearch), 0.5 μg/mL CpG ODN2006 (TLR9 agonist, Invivogen), 2.0 μg/mL Gardiquimod or 1.0 μg/mL Loxoribine (TLR7 agonists, Invivogen). Expression of surface activation markers was analyzed after 48 hours using flow cytometry. For inhibition experiments B cell cultures were preincubated with the specific inhibitors for 45 minutes. Intracellular phosphospecific flow cytometric analysis was performed as described before (26 (link)). Cells were acquired with a FACSCalibur or LSR II (BD Biosciences) and analyzed with FlowJo software. Information on the antibodies and inhibitors used is provided in the supplemental Methods section.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!